JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

Benzinga Newsdesk www.benzinga.com Positive 59.1%

Neg 0% Neu 0% Pos 59.1%

JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.